{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Mycobacterium tuberculosis", "NLRP3 inflammasomes", "alveolar macrophages", "immunopathology", "interleukin 1 cytokines", "medicinal plant derivatives", "medicinal plants", "pulmonary epithelial cells"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34502407", "DateCompleted": {"Year": "2021", "Month": "10", "Day": "25"}, "DateRevised": {"Year": "2021", "Month": "10", "Day": "25"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "08", "Day": "31"}], "Language": ["eng"], "ELocationID": ["9497", "10.3390/ijms22179497"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "22", "Issue": "17", "PubDate": {"Year": "2021", "Month": "Aug", "Day": "31"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "Exploring the Use of Medicinal Plants and Their Bioactive Derivatives as Alveolar NLRP3 Inflammasome Regulators during <i>Mycobacterium tuberculosis</i> Infection.", "Abstract": {"AbstractText": ["<i>Mycobacterium tuberculosis</i>, the causative agent of tuberculosis (TB), is a successful intracellular pathogen that is responsible for the highest mortality rate among diseases caused by bacterial infections. During early interaction with the host innate cells, <i>M. tuberculosis</i> cell surface antigens interact with Toll like receptor 4 (TLR4) to activate the nucleotide-binding domain, leucine-rich-repeat containing family, pyrin domain-containing 3 (NLRP3) canonical, and non-canonical inflammasome pathways. NLRP3 inflammasome activation in the alveoli has been reported to contribute to the early inflammatory response that is needed for an effective anti-TB response through production of pro-inflammatory cytokines, including those of the Interleukin 1 (IL1) family. However, overstimulation of the alveolar NLRP3 inflammasomes can induce excessive inflammation that is pathological to the host. Several studies have explored the use of medicinal plants and/or their active derivatives to inhibit excessive stimulation of the inflammasomes and its associated factors, thus reducing immunopathological response in the host. This review describes the molecular mechanism of the NLRP3 inflammasome activation in the alveoli during <i>M. tuberculosis</i> infection. Furthermore, the mechanisms of inflammasome inhibition using medicinal plant and their derivatives will also be explored, thus offering a novel perspective on the alternative control strategies of <i>M. tuberculosis</i>-induced immunopathology."]}, "AuthorList": [{"Identifier": ["0000-0002-3759-7141"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Life Sciences, College of Agriculture, Engineering and Science, University of KwaZulu-Natal, Westville 3630, South Africa."}], "LastName": "Mvubu", "ForeName": "Nontobeko E", "Initials": "NE"}, {"Identifier": ["0000-0002-9033-5941"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Life Sciences, College of Agriculture, Engineering and Science, University of KwaZulu-Natal, Westville 3630, South Africa."}], "LastName": "Chiliza", "ForeName": "Thamsanqa E", "Initials": "TE"}], "GrantList": [{"GrantID": "UID: 129635 and UID: 129846", "Agency": "National Research Foundation", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antigens, Bacterial"}, {"RegistryNumber": "0", "NameOfSubstance": "Cytokines"}, {"RegistryNumber": "0", "NameOfSubstance": "Inflammasomes"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-1beta"}, {"RegistryNumber": "0", "NameOfSubstance": "NLR Family, Pyrin Domain-Containing 3 Protein"}, {"RegistryNumber": "0", "NameOfSubstance": "NLRP3 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Toll-Like Receptor 4"}, {"RegistryNumber": "144058-44-6", "NameOfSubstance": "Mycobacterium tuberculosis antigens"}], "MeshHeadingList": [{"QualifierName": ["immunology", "metabolism"], "DescriptorName": "Antigens, Bacterial"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cytokines"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Inflammasomes"}, {"QualifierName": [], "DescriptorName": "Inflammation"}, {"QualifierName": ["metabolism"], "DescriptorName": "Interleukin-1beta"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Macrophages, Alveolar"}, {"QualifierName": ["drug effects", "pathogenicity"], "DescriptorName": "Mycobacterium tuberculosis"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "NLR Family, Pyrin Domain-Containing 3 Protein"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["pathology"], "DescriptorName": "Pulmonary Alveoli"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["metabolism"], "DescriptorName": "Toll-Like Receptor 4"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Tuberculosis"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "WHO . Global Tuberculosis Report 2019. World Health Organization; Geneva, Switzerland: 2020."}, {"Citation": "Parwati I., van Crevel R., van Soolingen D. Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains. Lancet Infect. Dis. 2010;10:103\u2013111. doi: 10.1016/S1473-3099(09)70330-5.", "ArticleIdList": ["10.1016/S1473-3099(09)70330-5", "20113979"]}, {"Citation": "Getnet F., Demissie M., Assefa N., Mengistie B., Worku A. Delay in diagnosis of pulmonary tuberculosis in low-and middle-income settings: Systematic review and meta-analysis. BMC Pulm. Med. 2017;17:202. doi: 10.1186/s12890-017-0551-y.", "ArticleIdList": ["10.1186/s12890-017-0551-y", "PMC5729407", "29237451"]}, {"Citation": "Bello S., Afolabi R.F., Ajayi D.T., Sharma T., Owoeye D.O., Oduyoye O., Jasanya J. Empirical evidence of delays in diagnosis and treatment of pulmonary tuberculosis: Systematic review and meta-regression analysis. BMC Public Health. 2019;19:820. doi: 10.1186/s12889-019-7026-4.", "ArticleIdList": ["10.1186/s12889-019-7026-4", "PMC6593585", "31238906"]}, {"Citation": "Bhat K.H., Yaseen I. Mycobacterium: Research and Development. InTech Open; London, UK: 2018. Mycobacterium tuberculosis: Macrophage takeover and modulation of innate effector responses."}, {"Citation": "Ryndak M.B., Laal S. Mycobacterium tuberculosis Primary Infection and Dissemination: A Critical Role for Alveolar Epithelial Cells. Front. Cell. Infect. Microbiol. 2019;9:299. doi: 10.3389/fcimb.2019.00299.", "ArticleIdList": ["10.3389/fcimb.2019.00299", "PMC6712944", "31497538"]}, {"Citation": "Whitsett J.A., Alenghat T. Respiratory epithelial cells orchestrate pulmonary innate immunity. Nat. Immunol. 2015;16:27\u201335. doi: 10.1038/ni.3045.", "ArticleIdList": ["10.1038/ni.3045", "PMC4318521", "25521682"]}, {"Citation": "Lerner T.R., Borel S., Gutierrez M.G. The innate immune response in human tuberculosis. Cell Microbiol. 2015;17:1277\u20131285. doi: 10.1111/cmi.12480.", "ArticleIdList": ["10.1111/cmi.12480", "PMC4832344", "26135005"]}, {"Citation": "Davies J.A., Garrod D.R. Molecular aspects of the epithelial phenotype. Bioessays. 1997;19:699\u2013704. doi: 10.1002/bies.950190810.", "ArticleIdList": ["10.1002/bies.950190810", "9264252"]}, {"Citation": "Buckley A., Turner J.R. Cell Biology of Tight Junction Barrier Regulation and Mucosal Disease. Cold Spring Harb. Perspect. Biol. 2018;10:a029314. doi: 10.1101/cshperspect.a029314.", "ArticleIdList": ["10.1101/cshperspect.a029314", "PMC5749156", "28507021"]}, {"Citation": "Eisele N.A., Anderson D.M. Host defense and the airway epithelium: Frontline responses that protect against bacterial invasion and pneumonia. J. Pathog. 2011;2011:249802. doi: 10.4061/2011/249802.", "ArticleIdList": ["10.4061/2011/249802", "PMC3335569", "22567325"]}, {"Citation": "Ehrt S., Schnappinger D., Bekiranov S., Drenkow J., Shi S., Gingeras T.R., Gaasterland T., Schoolnik G., Nathan C. Reprogramming of the macrophage transcriptome in response to interferon-\u03b3 and Mycobacterium tuberculosis signaling roles of nitric oxide synthase-2 and phagocyte oxidase. J. Exp. Med. 2001;194:1123\u20131140. doi: 10.1084/jem.194.8.1123.", "ArticleIdList": ["10.1084/jem.194.8.1123", "PMC2193509", "11602641"]}, {"Citation": "Mihret A. The role of dendritic cells in Mycobacterium tuberculosis infection. Virulence. 2012;3:654\u2013659. doi: 10.4161/viru.22586.", "ArticleIdList": ["10.4161/viru.22586", "PMC3545947", "23154283"]}, {"Citation": "Kroon E.E., Coussens A.K., Kinnear C., Orlova M., M\u00f6ller M., Seeger A., Wilkinson R.J., Hoal E.G., Schurr E. Neutrophils: Innate Effectors of TB Resistance? Front. Immunol. 2018;9:2637. doi: 10.3389/fimmu.2018.02637.", "ArticleIdList": ["10.3389/fimmu.2018.02637", "PMC6246713", "30487797"]}, {"Citation": "Silva-Sanchez A., Meza-P\u00e9rez S., Mu\u00f1oz-Teneria F., Mata D., Calderon-Amador J., Estrada-Parra S., Hern\u00e1ndez-Pando R., Estrada-Garc\u00eda I., Flores-Romo L. Understanding Tuberculosis-Deciphering the Secret Life of the Bacilli. InTech Open; London, UK: 2012. Mycobacterial Strains of Different Virulence Trigger Dissimilar Patterns of Immune System Activation In Vivo."}, {"Citation": "Scordo J.M., Knoell D.L., Torrelles J.B. Alveolar epithelial cells in Mycobacterium tuberculosis infection: Active Players or Innocent Bystanders. J. Innate Immun. 2016;8:3\u201314. doi: 10.1159/000439275.", "ArticleIdList": ["10.1159/000439275", "PMC4724319", "26384325"]}, {"Citation": "Li Y., Wang Y., Liu X. The role of airway epithelial cells in response to mycobacteria infection. Clin. Dev. Immunol. 2012;2012:791392. doi: 10.1155/2012/791392.", "ArticleIdList": ["10.1155/2012/791392", "PMC3337601", "22570668"]}, {"Citation": "Faridgohar M., Nikoueinejad H. New findings of Toll-like receptors involved in Mycobacterium tuberculosis infection. Pathog. Glob. Health. 2017;111:256\u2013264. doi: 10.1080/20477724.2017.1351080.", "ArticleIdList": ["10.1080/20477724.2017.1351080", "PMC5560203", "28715935"]}, {"Citation": "Diamond C.E., Khameneh H.J., Brough D., Mortellaro A. Novel perspectives on non-canonical inflammasome activation. ImmunoTargets Ther. 2015;4:131.", "ArticleIdList": ["PMC4918253", "27471719"]}, {"Citation": "Dorhoi A., Nouailles G., J\u00f6rg S., Hagens K., Heinemann E., Pradl L., Oberbeck-M\u00fcller D., Duque-Correa M.A., Reece S.T., Ruland J. Activation of the NLRP3 inflammasome by Mycobacterium tuberculosis is uncoupled from susceptibility to active tuberculosis. Eur. J. Immunol. 2012;42:374\u2013384. doi: 10.1002/eji.201141548.", "ArticleIdList": ["10.1002/eji.201141548", "22101787"]}, {"Citation": "Kelley N., Jeltema D., Duan Y., He Y. The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation. Int. J. Mol. Sci. 2019;20:3328. doi: 10.3390/ijms20133328.", "ArticleIdList": ["10.3390/ijms20133328", "PMC6651423", "31284572"]}, {"Citation": "Jo E.-K., Kim J.K., Shin D.-M., Sasakawa C. Molecular mechanisms regulating NLRP3 inflammasome activation. Cell. Mol. Immunol. 2016;13:148\u2013159. doi: 10.1038/cmi.2015.95.", "ArticleIdList": ["10.1038/cmi.2015.95", "PMC4786634", "26549800"]}, {"Citation": "Jayaraman P., Sada-Ovalle I., Nishimura T., Anderson A.C., Kuchroo V.K., Remold H.G., Behar S.M. IL-1\u03b2 promotes antimicrobial immunity in macrophages by regulating TNFR signaling and caspase-3 activation. J. Immunol. 2013;190:4196\u20134204. doi: 10.4049/jimmunol.1202688.", "ArticleIdList": ["10.4049/jimmunol.1202688", "PMC3622150", "23487424"]}, {"Citation": "Krishnan N., Robertson B.D., Thwaites G. Pathways of IL-1\u03b2 secretion by macrophages infected with clinical Mycobacterium tuberculosis strains. Tuberculosis. 2013;93:538\u2013547. doi: 10.1016/j.tube.2013.05.002.", "ArticleIdList": ["10.1016/j.tube.2013.05.002", "PMC3759846", "23849220"]}, {"Citation": "Mishra B.B., Rathinam V.A.K., Martens G.W., Martinot A.J., Kornfeld H., Fitzgerald K.A., Sassetti C.M. Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome-dependent processing of IL-1\u03b2. Nat. Immunol. 2013;14:52\u201360. doi: 10.1038/ni.2474.", "ArticleIdList": ["10.1038/ni.2474", "PMC3721324", "23160153"]}, {"Citation": "Ma J., Zhao S., Gao X., Wang R., Liu J., Zhou X., Zhou Y. The roles of inflammasomes in host defense against Mycobacterium tuberculosis. Pathogens. 2021;10:120. doi: 10.3390/pathogens10020120.", "ArticleIdList": ["10.3390/pathogens10020120", "PMC7911501", "33503864"]}, {"Citation": "Anochie P.I., Ndingkokhar B., Bueno J., Anyiam F.E., Ossai-Chidi L.N., Onyeneke E.C., Onyeozirila A.C. African Medicinal Plants that Can Control or Cure Tuberculosis. Int. J. Pharm. Sci. Dev. Res. 2018;4:1\u20138."}, {"Citation": "Rahman F., Hossan S., Mollik A., Islam T., Jahan R., Taufiq-Ur-Rahman M., Rahmatullah M. Medicinal plants used against tuberculosis by traditional medicinal practitioners of Bogra district, Bangladesh. Planta Med. 2009;75:PD64. doi: 10.1055/s-0029-1234543.", "ArticleIdList": ["10.1055/s-0029-1234543"]}, {"Citation": "Gupta V.K., Kumar M.M., Bisht D., Kaushik A. Plants in our combating strategies against Mycobacterium tuberculosis: Progress made and obstacles met. Pharm. Biol. 2017;55:1536\u20131544. doi: 10.1080/13880209.2017.1309440.", "ArticleIdList": ["10.1080/13880209.2017.1309440", "PMC6130758", "28385088"]}, {"Citation": "Semenya S.S., Maroyi A. Medicinal plants used for the treatment of tuberculosis by Bapedi traditional healers in three districts of the Limpopo Province, South Africa. Afr. J. Tradit. Complement. Altern. Med. 2012;10:316\u2013323. doi: 10.4314/ajtcam.v10i2.17.", "ArticleIdList": ["10.4314/ajtcam.v10i2.17", "PMC3746579", "24146456"]}, {"Citation": "Zhang Q., Jiang X., He W., Wei K., Sun J., Qin X., Zheng Y., Jiang X. MCL Plays an Anti-Inflammatory Role in Mycobacterium tuberculosis Induced Immune Response by Inhibiting NF-\u03baB and NLRP3 Inflammasome Activation. Mediat. Inflamm. 2017;2017:2432904. doi: 10.1155/2017/2432904.", "ArticleIdList": ["10.1155/2017/2432904", "PMC5470027", "28642632"]}, {"Citation": "Zhang Q., Sun J., Fu Y., He W., Li Y., Tan H., Xu H., Jiang X. Guttiferone K Exerts the Anti-inflammatory Effect on Mycobacterium tuberculosis-(H37Ra-) Infected Macrophages by Targeting the TLR/IRAK-1 Mediated Akt and NF-\u03baB Pathway. Mediat. Inflamm. 2020;2020 doi: 10.1155/2020/8528901.", "ArticleIdList": ["10.1155/2020/8528901", "PMC7569438", "33100904"]}, {"Citation": "Madikizela B., Ndhlala A., Finnie J., Van Staden J. Antimycobacterial, anti-inflammatory and genotoxicity evaluation of plants used for the treatment of tuberculosis and related symptoms in South Africa. J. Ethnopharmacol. 2014;153:386\u2013391. doi: 10.1016/j.jep.2014.02.034.", "ArticleIdList": ["10.1016/j.jep.2014.02.034", "24576406"]}, {"Citation": "Zhang Q., Sun J., Wang Y., He W., Wang L., Zheng Y., Wu J., Zhang Y., Jiang X. Antimycobacterial and Anti-inflammatory Mechanisms of Baicalin via Induced Autophagy in Macrophages Infected with Mycobacterium tuberculosis. Front. Microbiol. 2017;8 doi: 10.3389/fmicb.2017.02142.", "ArticleIdList": ["10.3389/fmicb.2017.02142", "PMC5673628", "29163427"]}, {"Citation": "He W., Sun J., Zhang Q., Li Y., Fu Y., Zheng Y., Jiang X. Andrographolide exerts anti-inflammatory effects in Mycobacterium tuberculosis-infected macrophages by regulating the Notch1/Akt/NF-\u03baB axis. J. Leukoc. Biol. 2020;108:1747\u20131764. doi: 10.1002/JLB.3MA1119-584RRR.", "ArticleIdList": ["10.1002/JLB.3MA1119-584RRR", "32991757"]}, {"Citation": "Velasco-Vel\u00e1zquez M.A., Barrera D., Gonz\u00e1lez-Arenas A., Rosales C., Agramonte-Hevia J. Macrophage\u2014Mycobacterium tuberculosis interactions: Role of complement receptor 3. Microb. Pathog. 2003;35:125\u2013131. doi: 10.1016/S0882-4010(03)00099-8.", "ArticleIdList": ["10.1016/S0882-4010(03)00099-8", "12927520"]}, {"Citation": "Cywes C., Godenir N.L., Hoppe H.C., Scholle R.R., Steyn L.M., Kirsch R.E., Ehlers M. Nonopsonic binding of Mycobacterium tuberculosis to human complement receptor type 3 expressed in Chinese hamster ovary cells. Infect. Immun. 1996;64:5373\u20135383. doi: 10.1128/iai.64.12.5373-5383.1996.", "ArticleIdList": ["10.1128/iai.64.12.5373-5383.1996", "PMC174532", "8945590"]}, {"Citation": "Maglione P.J., Xu J., Casadevall A., Chan J. Fc gamma receptors regulate immune activation and susceptibility during Mycobacterium tuberculosis infection. J. Immunol. 2008;180:3329\u20133338. doi: 10.4049/jimmunol.180.5.3329.", "ArticleIdList": ["10.4049/jimmunol.180.5.3329", "18292558"]}, {"Citation": "Melo M.D., Catchpole I.R., Haggar G., Stokes R.W. Utilization of CD11b knockout mice to characterize the role of complement receptor 3 (CR3, CD11b/CD18) in the growth of Mycobacterium tuberculosis in macrophages. Cell. Immunol. 2000;205:13\u201323. doi: 10.1006/cimm.2000.1710.", "ArticleIdList": ["10.1006/cimm.2000.1710", "11078603"]}, {"Citation": "Schlesinger L.S., Azad A.K., Torrelles J.B., Roberts E., Vergne I., Deretic V. Determinants of phagocytosis, phagosome biogenesis and autophagy for Mycobacterium tuberculosis. Handb. Tuberc. Immunol. Cell Biol. 2008;1:22."}, {"Citation": "Schlesinger L.S., Bellinger-Kawahara C.G., Payne N.R., Horwitz M.A. Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. J. Immunol. 1990;144:2771\u20132780.", "ArticleIdList": ["2108212"]}, {"Citation": "Ferguson J.S., Weis J.J., Martin J.L., Schlesinger L.S. Complement protein C3 binding to Mycobacterium tuberculosis is initiated by the classical pathway in human bronchoalveolar lavage fluid. Infect. Immun. 2004;72:2564. doi: 10.1128/IAI.72.5.2564-2573.2004.", "ArticleIdList": ["10.1128/IAI.72.5.2564-2573.2004", "PMC387845", "15102764"]}, {"Citation": "Armstrong J.A., Hart P.D. Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival. J. Exp. Med. 1975;142:1\u201316. doi: 10.1084/jem.142.1.1.", "ArticleIdList": ["10.1084/jem.142.1.1", "PMC2189870", "807671"]}, {"Citation": "Kang P.B., Azad A.K., Torrelles J.B., Kaufman T.M., Beharka A., Tibesar E., DesJardin L.E., Schlesinger L.S. The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis. J. Exp. Med. 2005;202:987\u2013999. doi: 10.1084/jem.20051239.", "ArticleIdList": ["10.1084/jem.20051239", "PMC2213176", "16203868"]}, {"Citation": "Rajaram M.V.S., Arnett E., Azad A.K., Guirado E., Ni B., Gerberick A.D., He L.Z., Keler T., Thomas L.J., Lafuse W.P., et al. M. tuberculosis\u2014Initiated Human Mannose Receptor Signaling Regulates Macrophage Recognition and Vesicle Trafficking by FcR\u03b3-Chain, Grb2, and SHP-1. Cell Rep. 2017;21:126\u2013140. doi: 10.1016/j.celrep.2017.09.034.", "ArticleIdList": ["10.1016/j.celrep.2017.09.034", "PMC5960073", "28978467"]}, {"Citation": "Garcia-Aguilar T., Espinosa-Cueto P., Magallanes-Puebla A., Mancilla R. The Mannose Receptor Is Involved in the Phagocytosis of Mycobacteria-Induced Apoptotic Cells. J. Immunol. Res. 2016;2016:3845247. doi: 10.1155/2016/3845247.", "ArticleIdList": ["10.1155/2016/3845247", "PMC4931060", "27413759"]}, {"Citation": "Schlesinger L.S., Kaufman T.M., Iyer S., Hull S.R., Marchiando L.K. Differences in mannose receptor-mediated uptake of lipoarabinomannan from virulent and attenuated strains of Mycobacterium tuberculosis by human macrophages. J. Immunol. 1996;157:4568\u20134575.", "ArticleIdList": ["8906835"]}, {"Citation": "Gaynor C.D., McCormack F.X., Voelker D.R., McGowan S.E., Schlesinger L.S. Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages. J. Immunol. 1995;155:5343\u20135351.", "ArticleIdList": ["7594549"]}, {"Citation": "Pasula R., Downing J.F., Wright J.R., Kachel D.L., Davis T.E., Jr., Martin W.J. Surfactant protein A (SP-A) mediates attachment of Mycobacterium tuberculosis to murine alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 1997;17:209\u2013217. doi: 10.1165/ajrcmb.17.2.2469.", "ArticleIdList": ["10.1165/ajrcmb.17.2.2469", "9271309"]}, {"Citation": "Van de Veerdonk F.L., Teirlinck A.C., Kleinnijenhuis J., Kullberg B.J., van Crevel R., van der Meer J.W., Joosten L.A., Netea M.G. Mycobacterium tuberculosis induces IL-17A responses through TLR4 and dectin-1 and is critically dependent on endogenous IL-1. J. Leukoc. Biol. 2010;88:227\u2013232. doi: 10.1189/jlb.0809550.", "ArticleIdList": ["10.1189/jlb.0809550", "20299682"]}, {"Citation": "Yadav M., Schorey J.S. The \u03b2-glucan receptor dectin-1 functions together with TLR2 to mediate macrophage activation by mycobacteria. Blood. 2006;108:3168\u20133175. doi: 10.1182/blood-2006-05-024406.", "ArticleIdList": ["10.1182/blood-2006-05-024406", "PMC1895517", "16825490"]}, {"Citation": "Kleinnijenhuis J., Joosten L.A., van de Veerdonk F.L., Savage N., van Crevel R., Kullberg B.J., van der Ven A., Ottenhoff T.H., Dinarello C.A., van der Meer J.W. Transcriptional and inflammasome-mediated pathways for the induction of IL-1\u03b2 production by Mycobacterium tuberculosis. Eur. J. Immunol. 2009;39:1914\u20131922. doi: 10.1002/eji.200839115.", "ArticleIdList": ["10.1002/eji.200839115", "19544485"]}, {"Citation": "Shams H., Wizel B., Lakey D.L., Samten B., Vankayalapati R., Valdivia R.H., Kitchens R.L., Griffith D.E., Barnes P.F. The CD14 receptor does not mediate entry of Mycobacterium tuberculosis into human mononuclear phagocytes. FEMS Immunol. Med. Microbiol. 2003;36:63\u201369. doi: 10.1016/S0928-8244(03)00039-7.", "ArticleIdList": ["10.1016/S0928-8244(03)00039-7", "12727367"]}, {"Citation": "Yoshida A., Inagawa H., Kohchi C., Nishizawa T., Soma G.-I. The role of toll-like receptor 2 in survival strategies of Mycobacterium tuberculosis in macrophage phagosomes. Anticancer Res. 2009;29:907\u2013910.", "ArticleIdList": ["19414326"]}, {"Citation": "S\u00e1nchez D., Rojas M., Hern\u00e1ndez I., Radzioch D., Garc\u00eda L.F., Barrera L.F. Role of TLR2-and TLR4-mediated signaling in Mycobacterium tuberculosis-induced macrophage death. Cell. Immunol. 2010;260:128\u2013136. doi: 10.1016/j.cellimm.2009.10.007.", "ArticleIdList": ["10.1016/j.cellimm.2009.10.007", "19919859"]}, {"Citation": "Bermudez L.E., Goodman J. Mycobacterium tuberculosis invades and replicates within type II alveolar cells. Infect. Immun. 1996;64:1400\u20131406. doi: 10.1128/iai.64.4.1400-1406.1996.", "ArticleIdList": ["10.1128/iai.64.4.1400-1406.1996", "PMC173932", "8606107"]}, {"Citation": "Lee H.M., Yuk J.M., Shin D.M., Jo E.K. Dectin-1 is inducible and plays an essential role for mycobacteria-induced innate immune responses in airway epithelial cells. J. Clin. Immunol. 2009;29:795\u2013805. doi: 10.1007/s10875-009-9319-3.", "ArticleIdList": ["10.1007/s10875-009-9319-3", "19633936"]}, {"Citation": "Hadifar S., Behrouzi A., Fateh A., Khatami S., Jamnani F.R., Siadat S.D., Vaziri F. Interruption of signaling pathways in lung epithelial cell by Mycobacterium tuberculosis. bioRxiv. 2018 doi: 10.1101/308882.", "ArticleIdList": ["10.1101/308882", "30192006"]}, {"Citation": "Sequeira P.C., Senaratne R.H., Riley L.W. Inhibition of toll-like receptor 2 (TLR-2)-mediated response in human alveolar epithelial cells by mycolic acids and Mycobacterium tuberculosis mce1 operon mutant. Pathog. Dis. 2014;70:132\u2013140. doi: 10.1111/2049-632X.12110.", "ArticleIdList": ["10.1111/2049-632X.12110", "PMC6433132", "24190334"]}, {"Citation": "Mvubu N.E., Pillay B., McKinnon L.R., Pillay M. Mycobacterium tuberculosis strains induce strain-specific cytokine and chemokine response in pulmonary epithelial cells. Cytokine. 2018;104:53\u201364. doi: 10.1016/j.cyto.2017.09.027.", "ArticleIdList": ["10.1016/j.cyto.2017.09.027", "29032986"]}, {"Citation": "Troutman T.D., Bazan J.F., Pasare C. Toll-like receptors, signaling adapters and regulation of the pro-inflammatory response by PI3K. Cell Cycle. 2012;11:3559\u20133567. doi: 10.4161/cc.21572.", "ArticleIdList": ["10.4161/cc.21572", "PMC3478307", "22895011"]}, {"Citation": "Mvubu N.E., Pillay B., Gamieldien J., Bishai W., Pillay M. Canonical pathways, networks and transcriptional factor regulation by clinical strains of Mycobacterium tuberculosis in pulmonary alveolar epithelial cells. Tuberculosis. 2016;97:73\u201385. doi: 10.1016/j.tube.2015.12.002.", "ArticleIdList": ["10.1016/j.tube.2015.12.002", "26980499"]}, {"Citation": "Kim K., Sohn H., Kim J.-S., Choi H.-G., Byun E.-H., Lee K.-I., Shin S.J., Song C.-H., Park J.-K., Kim H.-J. Mycobacterium tuberculosis Rv0652 stimulates production of tumour necrosis factor and monocytes chemoattractant protein-1 in macrophages through the Toll-like receptor 4 pathway. Immunology. 2012;136:231\u2013240. doi: 10.1111/j.1365-2567.2012.03575.x.", "ArticleIdList": ["10.1111/j.1365-2567.2012.03575.x", "PMC3403266", "22385341"]}, {"Citation": "Fremond C.M., Togbe D., Doz E., Rose S., Vasseur V., Maillet I., Jacobs M., Ryffel B., Quesniaux V.F.J. IL-1 Receptor-Mediated Signal Is an Essential Component of MyD88-Dependent Innate Response to Mycobacterium tuberculosis Infection. J. Immunol. 2007;179:1178\u20131189. doi: 10.4049/jimmunol.179.2.1178.", "ArticleIdList": ["10.4049/jimmunol.179.2.1178", "17617611"]}, {"Citation": "Scanga C.A., Bafica A., Feng C.G., Cheever A.W., Hieny S., Sher A. MyD88-deficient mice display a profound loss in resistance to Mycobacterium tuberculosis associated with partially impaired Th1 cytokine and nitric oxide synthase 2 expression. Infect. Immun. 2004;72:2400. doi: 10.1128/IAI.72.4.2400-2404.2004.", "ArticleIdList": ["10.1128/IAI.72.4.2400-2404.2004", "PMC375220", "15039368"]}, {"Citation": "Sugawara I., Yamada H., Mizuno S., Takeda K., Akira S. Mycobacterial infection in MyD88-deficient mice. Microbiol. Immunol. 2003;47:841\u2013847. doi: 10.1111/j.1348-0421.2003.tb03450.x.", "ArticleIdList": ["10.1111/j.1348-0421.2003.tb03450.x", "14638995"]}, {"Citation": "Pellegrini C., Antonioli L., Lopez-Castejon G., Blandizzi C., Fornai M. Canonical and non-canonical activation of NLRP3 inflammasome at the crossroad between immune tolerance and intestinal inflammation. Front. Immunol. 2017;8:36. doi: 10.3389/fimmu.2017.00036.", "ArticleIdList": ["10.3389/fimmu.2017.00036", "PMC5263152", "28179906"]}, {"Citation": "Wawrocki S., Druszczynska M. Inflammasomes in Mycobacterium tuberculosis-Driven Immunity. Can. J. Infect. Dis. Med. Microbiol. 2017;2017:2309478. doi: 10.1155/2017/2309478.", "ArticleIdList": ["10.1155/2017/2309478", "PMC5733865", "29348763"]}, {"Citation": "Hosseinian N., Cho Y., Lockey R.F., Kolliputi N. The role of the NLRP3 inflammasome in pulmonary diseases. Ther. Adv. Respir. Dis. 2015;9:188\u2013197. doi: 10.1177/1753465815586335.", "ArticleIdList": ["10.1177/1753465815586335", "26012351"]}, {"Citation": "Lamkanfi M., Dixit V.M. Mechanisms and functions of inflammasomes. Cell. 2014;157:1013\u20131022. doi: 10.1016/j.cell.2014.04.007.", "ArticleIdList": ["10.1016/j.cell.2014.04.007", "24855941"]}, {"Citation": "Sharma D., Kanneganti T.-D. The cell biology of inflammasomes: Mechanisms of inflammasome activation and regulation. J. Cell Biol. 2016;213:617\u2013629. doi: 10.1083/jcb.201602089.", "ArticleIdList": ["10.1083/jcb.201602089", "PMC4915194", "27325789"]}, {"Citation": "Amaral E.P., Riteau N., Moayeri M., Maier N., Mayer-Barber K.D., Pereira R.M., Lage S.L., Kubler A., Bishai W.R., D\u2019Imp\u00e9rio-Lima M.R., et al. Lysosomal Cathepsin Release Is Required for NLRP3-Inflammasome Activation by Mycobacterium tuberculosis in Infected Macrophages. Front. Immunol. 2018;9:1427. doi: 10.3389/fimmu.2018.01427.", "ArticleIdList": ["10.3389/fimmu.2018.01427", "PMC6021483", "29977244"]}, {"Citation": "Carmona J., Cruz A., Moreira-Teixeira L., Sousa C., Sousa J., Osorio N.S., Saraiva A.L., Svenson S., Kallenius G., Pedrosa J. Mycobacterium tuberculosis strains are differentially recognized by TLRs with an impact on the immune response. PLoS ONE. 2013;8:e67277. doi: 10.1371/journal.pone.0067277.", "ArticleIdList": ["10.1371/journal.pone.0067277", "PMC3693941", "23840651"]}, {"Citation": "Amaral E.P., Andrade B.d.B. Nuclear Factor \u03baB Activation Pathways during Mycobacterium tuberculosis Infection. Clin. Med. Insights Case Rep. 2017;9:1\u201310."}, {"Citation": "Pechkovsky D.V., Goldmann T., Vollmer E., M\u00fcller-Quernheim J., Zissel G. Interleukin-18 expression by alveolar epithelial cells type II in tuberculosis and sarcoidosis. FEMS Immunol. Med. Microbiol. 2006;46:30\u201338. doi: 10.1111/j.1574-695X.2005.00013.x.", "ArticleIdList": ["10.1111/j.1574-695X.2005.00013.x", "16420594"]}, {"Citation": "Ramsugit S., Pillay B., Pillay M. Evaluation of the role of Mycobacterium tuberculosis pili (MTP) as an adhesin, invasin, and cytokine inducer of epithelial cells. Braz. J. Infect. Dis. 2016;20:160\u2013165. doi: 10.1016/j.bjid.2015.11.002.", "ArticleIdList": ["10.1016/j.bjid.2015.11.002", "PMC9427661", "26748229"]}, {"Citation": "Juffermans N.P., Florquin S., Camoglio L., Verbon A., Kolk A.H., Speelman P., van Deventer S.J.H., van der Poll T. Interleukin-1 Signaling Is Essential for Host Defense during Murine Pulmonary Tuberculosis. J. Infect. Dis. 2000;182:902\u2013908. doi: 10.1086/315771.", "ArticleIdList": ["10.1086/315771", "10950787"]}, {"Citation": "Jung B.-G., Vankayalapati R., Samten B. Mycobacterium tuberculosis stimulates IL-1\u03b2 production by macrophages in an ESAT-6 dependent manner with the involvement of serum amyloid A3. Mol. Immunol. 2021;135:285\u2013293. doi: 10.1016/j.molimm.2021.04.022.", "ArticleIdList": ["10.1016/j.molimm.2021.04.022", "33957478"]}, {"Citation": "Yamada H., Mizumo S., Horai R., Iwakura Y., Sugawara I. Protective role of interleukin-1 in mycobacterial infection in IL-1 \u03b1/\u03b2 double-knockout mice. Lab. Investig. 2000;80:759\u2013767. doi: 10.1038/labinvest.3780079.", "ArticleIdList": ["10.1038/labinvest.3780079", "10830786"]}, {"Citation": "Oh C., Verma A., Aachoui Y. Caspase-11 Non-canonical Inflammasomes in the Lung. Front. Immunol. 2020;11 doi: 10.3389/fimmu.2020.01895.", "ArticleIdList": ["10.3389/fimmu.2020.01895", "PMC7472987", "32973786"]}, {"Citation": "Chaves M.M., Sinflorio D.A., Thorstenberg M.L., Martins M.D.A., Moreira-Souza A.C.A., Rangel T.P., Silva C.L., Bellio M., Canetti C., Coutinho-Silva R. Non-canonical NLRP3 inflammasome activation and IL-1\u03b2 signaling are necessary to L. amazonensis control mediated by P2X7 receptor and leukotriene B4. PLoS Pathog. 2019;15:e1007887. doi: 10.1371/journal.ppat.1007887.", "ArticleIdList": ["10.1371/journal.ppat.1007887", "PMC6622556", "31233552"]}, {"Citation": "Gutierrez M.G., Master S.S., Singh S.B., Taylor G.A., Colombo M.I., Deretic V. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell. 2004;119:753\u2013766. doi: 10.1016/j.cell.2004.11.038.", "ArticleIdList": ["10.1016/j.cell.2004.11.038", "15607973"]}, {"Citation": "Mishra B.B., Moura-Alves P., Sonawane A., Hacohen N., Griffiths G., Moita L.F., Anes E. Mycobacterium tuberculosis protein ESAT-6 is a potent activator of the NLRP3/ASC inflammasome. Cell. Microbiol. 2010;12:1046\u20131063. doi: 10.1111/j.1462-5822.2010.01450.x.", "ArticleIdList": ["10.1111/j.1462-5822.2010.01450.x", "20148899"]}, {"Citation": "Schneider B.E., Korbel D., Hagens K., Koch M., Raupach B., Enders J., Kaufmann S.H., Mittr\u00fccker H.W., Schaible U.E. A role for IL-18 in protective immunity against Mycobacterium tuberculosis. Eur. J. Immunol. 2010;40:396\u2013405. doi: 10.1002/eji.200939583.", "ArticleIdList": ["10.1002/eji.200939583", "PMC3189623", "19950174"]}, {"Citation": "Nakanishi K. Unique action of interleukin-18 on T cells and other immune cells. Front. Immunol. 2018;9:763. doi: 10.3389/fimmu.2018.00763.", "ArticleIdList": ["10.3389/fimmu.2018.00763", "PMC5920033", "29731751"]}, {"Citation": "Netea M.G., Kullberg B.J., Verschueren I., Meer J.W.V.d. Interleukin-18 induces production of proinflammatory cytokines in mice: No intermediate role for the cytokines of the tumor necrosis factor family and interleukin-1\u03b2. Eur. J. Immunol. 2000;30:3057\u20133060. doi: 10.1002/1521-4141(200010)30:10<3057::AID-IMMU3057>3.0.CO;2-P.", "ArticleIdList": ["10.1002/1521-4141(200010)30:10<3057::AID-IMMU3057>3.0.CO;2-P", "11069090"]}, {"Citation": "Puren A.J., Fantuzzi G., Gu Y., Su M., Dinarello C.A. Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells. J. Clin. Investig. 1998;101:711\u2013721. doi: 10.1172/JCI1379.", "ArticleIdList": ["10.1172/JCI1379", "PMC508617", "9449707"]}, {"Citation": "Sugawara I., Yamada H., Kaneko H., Mizuno S., Takeda K., Akira S. Role of interleukin-18 (IL-18) in mycobacterial infection in IL-18-gene-disrupted mice. Infect. Immun. 1999;67:2585\u20132589. doi: 10.1128/IAI.67.5.2585-2589.1999.", "ArticleIdList": ["10.1128/IAI.67.5.2585-2589.1999", "PMC116007", "10225924"]}, {"Citation": "Kumar N.P., Moideen K., Banurekha V.V., Nair D., Babu S. Plasma Proinflammatory Cytokines Are Markers of Disease Severity and Bacterial Burden in Pulmonary Tuberculosis. Open Forum Infect. Dis. 2019;6:ofz257. doi: 10.1093/ofid/ofz257.", "ArticleIdList": ["10.1093/ofid/ofz257", "PMC6602384", "31281858"]}, {"Citation": "Chao W.-C., Yen C.-L., Hsieh C.-Y., Huang Y.-F., Tseng Y.-L., Nigrovic P.A., Shieh C.-C. Mycobacterial infection induces higher interleukin-1\u03b2 and dysregulated lung inflammation in mice with defective leukocyte NADPH oxidase. PLoS ONE. 2017;12:e0189453. doi: 10.1371/journal.pone.0189453.", "ArticleIdList": ["10.1371/journal.pone.0189453", "PMC5724816", "29228045"]}, {"Citation": "Wang Y., Hu C., Wang Z., Kong H., Xie W., Wang H. Serum IL-1\u03b2 and IL-18 correlate with ESR and CRP in multidrug-resistant tuberculosis patients. J. Biomed. Res. 2015;29:426\u2013428. doi: 10.7555/JBR.29.20150077.", "ArticleIdList": ["10.7555/JBR.29.20150077", "PMC4585440", "26445573"]}, {"Citation": "Santucci N., D\u2019Attilio L., Besedovsky H., Del Rey A., Bay M.L., Bottasso O. A clinical correlate of the dysregulated immunoendocrine response in human tuberculosis. Neuroimmunomodulation. 2010;17:184\u2013187. doi: 10.1159/000258719.", "ArticleIdList": ["10.1159/000258719", "20134198"]}, {"Citation": "Boldrin F., Provvedi R., Cioetto Mazzab\u00f2 L., Segafreddo G., Manganelli R. Tolerance and Persistence to Drugs: A Main Challenge in the Fight Against Mycobacterium tuberculosis. Front. Microbiol. 2020;11:1924. doi: 10.3389/fmicb.2020.01924.", "ArticleIdList": ["10.3389/fmicb.2020.01924", "PMC7479264", "32983003"]}, {"Citation": "Mandal S., Njikan S., Kumar A., Early J.V., Parish T. The relevance of persisters in tuberculosis drug discovery. Microbiology. 2019;165:492\u2013499. doi: 10.1099/mic.0.000760.", "ArticleIdList": ["10.1099/mic.0.000760", "30775961"]}, {"Citation": "Sarathy J.P., Via L.E., Weiner D., Blanc L., Boshoff H., Eugenin E.A., Barry III C.E., Dartois V.A. Extreme drug tolerance of Mycobacterium tuberculosis in caseum. Antimicrob. Agents Chemother. 2018;62:e02266-17. doi: 10.1128/AAC.02266-17.", "ArticleIdList": ["10.1128/AAC.02266-17", "PMC5786764", "29203492"]}, {"Citation": "Kahaliw W., Aseffa A., Abebe M., Teferi M., Engidawork E. Evaluation of the antimycobacterial activity of crude extracts and solvent fractions of selected Ethiopian medicinal plants. BMC Complement. Altern. Med. 2017;17:143. doi: 10.1186/s12906-017-1563-0.", "ArticleIdList": ["10.1186/s12906-017-1563-0", "PMC5343536", "28274226"]}, {"Citation": "Gemechu A., Giday M., Worku A., Ameni G. In vitro Anti-mycobacterial activity of selected medicinal plants against Mycobacterium tuberculosis and Mycobacterium bovis Strains. BMC Complement. Altern. Med. 2013;13:291. doi: 10.1186/1472-6882-13-291.", "ArticleIdList": ["10.1186/1472-6882-13-291", "PMC4228439", "24168665"]}, {"Citation": "Assam J.P.A., Tcham M.F.Y., Moni N.E.D.F., Betote D.P.H., Fossi T.C., Penlap B.V. Phytochemical screening, Antimycobacterial activity of three medicinal Cameroonians plants and Acute toxicity of hydroethanolic extract of Vitellaria paradoxa. J. Drug Deliv. Ther. 2020;10:96\u2013104. doi: 10.22270/jddt.v10i1-s.3848.", "ArticleIdList": ["10.22270/jddt.v10i1-s.3848"]}, {"Citation": "Fyhrquist P., Laakso I., Marco S.G., Julkunen-Tiitto R., Hiltunen R. Antimycobacterial activity of ellagitannin and ellagic acid derivate rich crude extracts and fractions of five selected species of Terminalia used for treatment of infectious diseases in African traditional medicine. S. Afr. J. Bot. 2014;90:1\u201316. doi: 10.1016/j.sajb.2013.08.018.", "ArticleIdList": ["10.1016/j.sajb.2013.08.018"]}, {"Citation": "Putri D.U., Rintiswati N., Soesatyo M.H., Haryana S.M. Immune modulation properties of herbal plant leaves: Phyllanthus niruri aqueous extract on immune cells of tuberculosis patient\u2014In vitro study. Nat. Prod. Res. 2018;32:463\u2013467. doi: 10.1080/14786419.2017.1311888.", "ArticleIdList": ["10.1080/14786419.2017.1311888", "28391709"]}, {"Citation": "Krug S., Parveen S., Bishai W.R. Host-Directed Therapies: Modulating Inflammation to Treat Tuberculosis. Front. Immunol. 2021;12 doi: 10.3389/fimmu.2021.660916.", "ArticleIdList": ["10.3389/fimmu.2021.660916", "PMC8089478", "33953722"]}, {"Citation": "Zumla A., Rao M., Dodoo E., Maeurer M. Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis. BMC Med. 2016;14:89. doi: 10.1186/s12916-016-0635-1.", "ArticleIdList": ["10.1186/s12916-016-0635-1", "PMC4908783", "27301245"]}, {"Citation": "Ahmed S., Raqib R., Gu\u00f0mundsson G.H., Bergman P., Agerberth B., Rekha R.S. Host-Directed Therapy as a Novel Treatment Strategy to Overcome Tuberculosis: Targeting Immune Modulation. Antibiotics. 2020;9:21. doi: 10.3390/antibiotics9010021.", "ArticleIdList": ["10.3390/antibiotics9010021", "PMC7168302", "31936156"]}, {"Citation": "Ji Q., Ding Y.-H., Sun Y., Zhang Y., Gao H.-E., Song H.-N., Yang M., Liu X.-L., Zhang Z.-X., Li Y.-H., et al. Antineoplastic effects and mechanisms of micheliolide in acute myelogenous leukemia stem cells. Oncotarget. 2016;7:65012\u201365023. doi: 10.18632/oncotarget.11342.", "ArticleIdList": ["10.18632/oncotarget.11342", "PMC5323134", "27542251"]}, {"Citation": "Viennois E., Xiao B., Ayyadurai S., Wang L., Wang P.G., Zhang Q., Chen Y., Merlin D. Micheliolide, a new sesquiterpene lactone that inhibits intestinal inflammation and colitis-associated cancer. Lab. Investig. 2014;94:950\u2013965. doi: 10.1038/labinvest.2014.89.", "ArticleIdList": ["10.1038/labinvest.2014.89", "25068660"]}, {"Citation": "Ivanescu B., Miron A., Corciova A. Sesquiterpene lactones from Artemisia genus: Biological activities and methods of analysis. J. Anal. Methods Chem. 2015;2015 doi: 10.1155/2015/247685.", "ArticleIdList": ["10.1155/2015/247685", "PMC4606394", "26495156"]}, {"Citation": "Picman A.K. Biological activities of sesquiterpene lactones. Biochem. Syst. Ecol. 1986;14:255\u2013281. doi: 10.1016/0305-1978(86)90101-8.", "ArticleIdList": ["10.1016/0305-1978(86)90101-8"]}, {"Citation": "Qin X., Jiang X., Jiang X., Wang Y., Miao Z., He W., Yang G., Lv Z., Yu Y., Zheng Y. Micheliolide inhibits LPS-induced inflammatory response and protects mice from LPS challenge. Sci. Rep. 2016;6:1\u201313. doi: 10.1038/srep23240.", "ArticleIdList": ["10.1038/srep23240", "PMC4794649", "26984741"]}, {"Citation": "Xu G., Feng C., Zhou Y., Han Q.-B., Qiao C.-F., Huang S.-X., Chang D.C., Zhao Q.-S., Luo K.Q., Xu H.-X. Bioassay and ultraperformance liquid chromatography/mass spectrometry guided isolation of apoptosis-inducing benzophenones and xanthone from the pericarp of Garcinia yunnanensis Hu. J. Agric. Food Chem. 2008;56:11144\u201311150. doi: 10.1021/jf802690g.", "ArticleIdList": ["10.1021/jf802690g", "19007298"]}, {"Citation": "Li H., Meng X.-x., Zhang L., Zhang B.-j., Liu X.-y., Fu W.-w., Tan H.-s., Lao Y.-z., Xu H.-x. Oblongifolin C and guttiferone K extracted from Garcinia yunnanensis fruit synergistically induce apoptosis in human colorectal cancer cells in vitro. Acta Pharmacol. Sin. 2017;38:252\u2013263. doi: 10.1038/aps.2016.101.", "ArticleIdList": ["10.1038/aps.2016.101", "PMC5309747", "27840412"]}, {"Citation": "Pu Z., Han C., Zhang W., Xu M., Wu Z., Liu Y., Wu M., Sun H., Xie H. Systematic understanding of the mechanism and effects of Arctigenin attenuates inflammation in dextran sulfate sodium-induced acute colitis through suppression of NLRP3 inflammasome by SIRT1. Am. J. Transl. Res. 2019;11:3992.", "ArticleIdList": ["PMC6684881", "31396314"]}, {"Citation": "Yuan R., Fan H., Cheng S., Gao W., Xu X., Lv S., Ye M., Wu M., Zhu X., Zhang Y. Silymarin prevents NLRP3 inflammasome activation and protects against intracerebral hemorrhage. Biomed. Pharmacother. 2017;93:308\u2013315. doi: 10.1016/j.biopha.2017.06.018.", "ArticleIdList": ["10.1016/j.biopha.2017.06.018", "28651232"]}, {"Citation": "Hu Q.-H., Zhang X., Pan Y., Li Y.-C., Kong L.-D. Allopurinol, quercetin and rutin ameliorate renal NLRP3 inflammasome activation and lipid accumulation in fructose-fed rats. Biochem. Pharmacol. 2012;84:113\u2013125. doi: 10.1016/j.bcp.2012.03.005.", "ArticleIdList": ["10.1016/j.bcp.2012.03.005", "22426011"]}, {"Citation": "Wang S., Wang J., Wei H., Gu T., Wang J., Wu Z., Yang Q. Genistein attenuates acute cerebral ischemic damage by inhibiting the NLRP3 inflammasome in reproductively senescent mice. Front. Aging Neurosci. 2020;12:153. doi: 10.3389/fnagi.2020.00153.", "ArticleIdList": ["10.3389/fnagi.2020.00153", "PMC7311792", "32625078"]}, {"Citation": "Budai M.M., Varga A., Milesz S., T\u0151zs\u00e9r J., Benk\u0151 S. Aloe vera downregulates LPS-induced inflammatory cytokine production and expression of NLRP3 inflammasome in human macrophages. Mol. Immunol. 2013;56:471\u2013479. doi: 10.1016/j.molimm.2013.05.005.", "ArticleIdList": ["10.1016/j.molimm.2013.05.005", "23911403"]}, {"Citation": "Gong Q., He L.-L., Wang M.-L., Ouyang H., Gao H.-W., Feng Y.-L., Yang S.-L., Du L.-J., Li J., Luo Y.-Y. Anemoside B4 protects rat kidney from adenine-induced injury by attenuating inflammation and fibrosis and enhancing podocin and nephrin expression. Evid. Based Complement. Altern. Med. 2019;2019 doi: 10.1155/2019/8031039.", "ArticleIdList": ["10.1155/2019/8031039", "PMC6582884", "31275420"]}, {"Citation": "Tsai P.-Y., Ka S.-M., Chang J.-M., Chen H.-C., Shui H.-A., Li C.-Y., Hua K.-F., Chang W.-L., Huang J.-J., Yang S.-S. Epigallocatechin-3-gallate prevents lupus nephritis development in mice via enhancing the Nrf2 antioxidant pathway and inhibiting NLRP3 inflammasome activation. Free Radic. Biol. Med. 2011;51:744\u2013754. doi: 10.1016/j.freeradbiomed.2011.05.016.", "ArticleIdList": ["10.1016/j.freeradbiomed.2011.05.016", "21641991"]}, {"Citation": "Ding S., Wang H., Wang M., Bai L., Yu P., Wu W. Resveratrol alleviates chronic \u201creal-world\u201d ambient particulate matter-induced lung inflammation and fibrosis by inhibiting NLRP3 inflammasome activation in mice. Ecotoxicol. Environ. Saf. 2019;182:109425. doi: 10.1016/j.ecoenv.2019.109425.", "ArticleIdList": ["10.1016/j.ecoenv.2019.109425", "31295660"]}, {"Citation": "Matias M.L., Gomes V.J., Romao-Veiga M., Ribeiro V.R., Nunes P.R., Romagnoli G.G., Peracoli J.C., Peracoli M.T.S. Silibinin downregulates the NF-\u03baB pathway and NLRP1/NLRP3 inflammasomes in monocytes from pregnant women with preeclampsia. Molecules. 2019;24:1548. doi: 10.3390/molecules24081548.", "ArticleIdList": ["10.3390/molecules24081548", "PMC6515043", "31010153"]}, {"Citation": "Wen Y., Pan M.M., Lv L.L., Tang T.T., Zhou L.T., Wang B., Liu H., Wang F.M., Ma K.L., Tang R.N. Artemisinin attenuates tubulointerstitial inflammation and fibrosis via the NF-\u03baB/NLRP3 pathway in rats with 5/6 subtotal nephrectomy. J. Cell. Biochem. 2019;120:4291\u20134300. doi: 10.1002/jcb.27714.", "ArticleIdList": ["10.1002/jcb.27714", "30260039"]}, {"Citation": "Zhang L., Wang X.Z., Li Y.S., Zhang L., Hao L.R. Icariin ameliorates IgA nephropathy by inhibition of nuclear factor kappa b/Nlrp3 pathway. FEBS Open Bio. 2017;7:54\u201363. doi: 10.1002/2211-5463.12161.", "ArticleIdList": ["10.1002/2211-5463.12161", "PMC5221456", "28097088"]}, {"Citation": "Tang J., Li Y., Wang J., Wu Q., Yan H. Polydatin suppresses the development of lung inflammation and fibrosis by inhibiting activation of the NACHT domain-, leucine-rich repeat-, and pyd-containing protein 3 inflammasome and the nuclear factor-\u03baB pathway after Mycoplasma pneumoniae infection. J. Cell. Biochem. 2019;120:10137\u201310144. doi: 10.1002/jcb.28297.", "ArticleIdList": ["10.1002/jcb.28297", "30548648"]}, {"Citation": "Kang L.-L., Zhang D.-M., Ma C.-H., Zhang J.-H., Jia K.-K., Liu J.-H., Wang R., Kong L.-D. Cinnamaldehyde and allopurinol reduce fructose-induced cardiac inflammation and fibrosis by attenuating CD36-mediated TLR4/6-IRAK4/1 signaling to suppress NLRP3 inflammasome activation. Sci. Rep. 2016;6:1\u201318. doi: 10.1038/srep27460.", "ArticleIdList": ["10.1038/srep27460", "PMC4897702", "27270216"]}, {"Citation": "Han W., Ma Q., Liu Y., Wu W., Tu Y., Huang L., Long Y., Wang W., Yee H., Wan Z., et al. Huangkui capsule alleviates renal tubular epithelial-mesenchymal transition in diabetic nephropathy via inhibiting NLRP3 inflammasome activation and TLR4/NF-\u03baB signaling. Phytomedicine. 2019;57:203\u2013214. doi: 10.1016/j.phymed.2018.12.021.", "ArticleIdList": ["10.1016/j.phymed.2018.12.021", "30785016"]}, {"Citation": "Chakravarti R.N., Chakravarti D. Andrographolide, the active constituent of Andrographis paniculata Nees; a preliminary communication. Ind. Med. Gaz. 1951;86:96\u201397.", "ArticleIdList": ["PMC5191793", "14860885"]}, {"Citation": "Okhuarobo A., Falodun J.E., Erharuyi O., Imieje V., Falodun A., Langer P. Harnessing the medicinal properties of Andrographis paniculata for diseases and beyond: A review of its phytochemistry and pharmacology. Asian Pac. J. Trop. Dis. 2014;4:213\u2013222. doi: 10.1016/S2222-1808(14)60509-0.", "ArticleIdList": ["10.1016/S2222-1808(14)60509-0"]}, {"Citation": "Li C.-W., Deng M.-Z., Gao Z.-J., Dang Y.-Y., Zheng G.-D., Yang X.-J., Chao Y.-X., Cai Y.-F., Wu X.-L. Effects of compound K, a metabolite of ginsenosides, on memory and cognitive dysfunction in db/db mice involve the inhibition of ER stress and the NLRP3 inflammasome pathway. Food Funct. 2020;11:4416\u20134427. doi: 10.1039/C9FO02602A.", "ArticleIdList": ["10.1039/C9FO02602A", "32374299"]}, {"Citation": "Chen W., Wang J., Luo Y., Wang T., Li X., Li A., Li J., Liu K., Liu B. Ginsenoside Rb1 and compound K improve insulin signaling and inhibit ER stress-associated NLRP3 inflammasome activation in adipose tissue. J. Ginseng Res. 2016;40:351\u2013358. doi: 10.1016/j.jgr.2015.11.002.", "ArticleIdList": ["10.1016/j.jgr.2015.11.002", "PMC5052408", "27746687"]}, {"Citation": "Gong Z., Zhou J., Li H., Gao Y., Xu C., Zhao S., Chen Y., Cai W., Wu J. Curcumin suppresses NLRP3 inflammasome activation and protects against LPS-induced septic shock. Mol. Nutr. Food Res. 2015;59:2132\u20132142. doi: 10.1002/mnfr.201500316.", "ArticleIdList": ["10.1002/mnfr.201500316", "26250869"]}, {"Citation": "Yu S.-X., Du C.-T., Chen W., Lei Q.-Q., Li N., Qi S., Zhang X.-J., Hu G.-Q., Deng X.-M., Han W.-Y. Genipin inhibits NLRP3 and NLRC4 inflammasome activation via autophagy suppression. Sci. Rep. 2015;5:1\u201312. doi: 10.1038/srep17935.", "ArticleIdList": ["10.1038/srep17935", "PMC4675967", "26659006"]}, {"Citation": "Pan C.-W., Pan Z.-Z., Hu J.-J., Chen W.-L., Zhou G.-Y., Lin W., Jin L.-X., Xu C.-L. Mangiferin alleviates lipopolysaccharide and D-galactosamine-induced acute liver injury by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation. Eur. J. Pharmacol. 2016;770:85\u201391. doi: 10.1016/j.ejphar.2015.12.006.", "ArticleIdList": ["10.1016/j.ejphar.2015.12.006", "26668000"]}, {"Citation": "Qiu H., Liu W., Lan T., Pan W., Chen X., Wu H., Xu D. Salvianolate reduces atrial fibrillation through suppressing atrial interstitial fibrosis by inhibiting TGF-\u03b21/Smad2/3 and TXNIP/NLRP3 inflammasome signaling pathways in post-MI rats. Phytomedicine. 2018;51:255\u2013265. doi: 10.1016/j.phymed.2018.09.238.", "ArticleIdList": ["10.1016/j.phymed.2018.09.238", "30466624"]}, {"Citation": "Hua K.F., Chou J.C., Ka S.M., Tasi Y.L., Chen A., Wu S.H., Chiu H.W., Wong W.T., Wang Y.F., Tsai C.L., et al. Cyclooxygenase-2 regulates NLRP3 inflammasome-derived IL-1\u03b2 production. J. Cell Physiol. 2015;230:863\u2013874. doi: 10.1002/jcp.24815.", "ArticleIdList": ["10.1002/jcp.24815", "25294243"]}, {"Citation": "Yang G., Jang J.H., Kim S.W., Han S.-H., Ma K.-H., Jang J.-K., Kang H.C., Cho Y.-Y., Lee H.S., Lee J.Y. Sweroside prevents non-alcoholic steatohepatitis by suppressing activation of the NLRP3 inflammasome. Int. J. Mol. Sci. 2020;21:2790. doi: 10.3390/ijms21082790.", "ArticleIdList": ["10.3390/ijms21082790", "PMC7216241", "32316419"]}, {"Citation": "He H., Jiang H., Chen Y., Ye J., Wang A., Wang C., Liu Q., Liang G., Deng X., Jiang W. Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity. Nat. Commun. 2018;9:1\u201312. doi: 10.1038/s41467-018-04947-6.", "ArticleIdList": ["10.1038/s41467-018-04947-6", "PMC6026158", "29959312"]}, {"Citation": "Gao Y., Lv X., Yang H., Peng L., Ci X. Isoliquiritigenin exerts antioxidative and anti-inflammatory effects via activating the KEAP-1/Nrf2 pathway and inhibiting the NF-\u03baB and NLRP3 pathways in carrageenan-induced pleurisy. Food Funct. 2020;11:2522\u20132534. doi: 10.1039/C9FO01984G.", "ArticleIdList": ["10.1039/C9FO01984G", "32141447"]}, {"Citation": "Wang Z., Xu G., Gao Y., Zhan X., Qin N., Fu S., Li R., Niu M., Wang J., Liu Y. Cardamonin from a medicinal herb protects against LPS-induced septic shock by suppressing NLRP3 inflammasome. Acta Pharm. Sin. B. 2019;9:734\u2013744. doi: 10.1016/j.apsb.2019.02.003.", "ArticleIdList": ["10.1016/j.apsb.2019.02.003", "PMC6664040", "31384534"]}, {"Citation": "Han X., Song J., Lian L.-H., Yao Y.-L., Shao D.-Y., Fan Y., Hou L.-S., Wang G., Zheng S., Wu Y.-L. Ginsenoside 25-och3-ppd promotes activity of lxrs to ameliorate p2x7r-mediated nlrp3 inflammasome in the development of hepatic fibrosis. J. Agric. Food Chem. 2018;66:7023\u20137035. doi: 10.1021/acs.jafc.8b01982.", "ArticleIdList": ["10.1021/acs.jafc.8b01982", "29929367"]}, {"Citation": "Jiang J., Sun X., Akther M., Lian M.-L., Quan L.-H., Koppula S., Han J.-H., Kopalli S.R., Kang T.-B., Lee K.-H. Ginsenoside metabolite 20 (S)-protopanaxatriol from Panax ginseng attenuates inflammation-mediated NLRP3 inflammasome activation. J. Ethnopharmacol. 2020;251:112564. doi: 10.1016/j.jep.2020.112564.", "ArticleIdList": ["10.1016/j.jep.2020.112564", "31926987"]}, {"Citation": "Shen X., Dong X., Han Y., Li Y., Ding S., Zhang H., Sun Z., Yin Y., Li W., Li W. Ginsenoside Rg1 ameliorates glomerular fibrosis during kidney aging by inhibiting NOX4 and NLRP3 inflammasome activation in SAMP8 mice. Int. Immunopharmacol. 2020;82:106339. doi: 10.1016/j.intimp.2020.106339.", "ArticleIdList": ["10.1016/j.intimp.2020.106339", "32114413"]}, {"Citation": "Shi Y., Wang H., Zheng M., Xu W., Yang Y., Shi F. Ginsenoside Rg3 suppresses the NLRP3 inflammasome activation through inhibition of its assembly. FASEB J. 2020;34:208\u2013221. doi: 10.1096/fj.201901537R.", "ArticleIdList": ["10.1096/fj.201901537R", "31914640"]}, {"Citation": "Li R., Lu K., Wang Y., Chen M., Zhang F., Shen H., Yao D., Gong K., Zhang Z. Triptolide attenuates pressure overload-induced myocardial remodeling in mice via the inhibition of NLRP3 inflammasome expression. Biochem. Biophys. Res. Commun. 2017;485:69\u201375. doi: 10.1016/j.bbrc.2017.02.021.", "ArticleIdList": ["10.1016/j.bbrc.2017.02.021", "28202417"]}, {"Citation": "Yan T., Wang H., Cao L., Wang Q., Takahashi S., Yagai T., Li G., Krausz K.W., Wang G., Gonzalez F.J. Glycyrrhizin alleviates nonalcoholic steatohepatitis via modulating bile acids and meta-inflammation. Drug Metab. Dispos. 2018;46:1310\u20131319. doi: 10.1124/dmd.118.082008.", "ArticleIdList": ["10.1124/dmd.118.082008", "PMC6081736", "29959134"]}, {"Citation": "Cui L., Li C., Zhuo Y., Yang L., Cui N., Li Y., Zhang S. Saikosaponin A inhibits the activation of pancreatic stellate cells by suppressing autophagy and the NLRP3 inflammasome via the AMPK/mTOR pathway. Biomed. Pharmacother. 2020;128:110216. doi: 10.1016/j.biopha.2020.110216.", "ArticleIdList": ["10.1016/j.biopha.2020.110216", "32497863"]}, {"Citation": "Liu S., Tian L., Chai G., Wen B., Wang B. Targeting heme oxygenase-1 by quercetin ameliorates alcohol-induced acute liver injury via inhibiting NLRP3 inflammasome activation. Food Funct. 2018;9:4184\u20134193. doi: 10.1039/C8FO00650D.", "ArticleIdList": ["10.1039/C8FO00650D", "29993075"]}, {"Citation": "Ding T., Wang S., Zhang X., Zai W., Fan J., Chen W., Bian Q., Luan J., Shen Y., Zhang Y. Kidney protection effects of dihydroquercetin on diabetic nephropathy through suppressing ROS and NLRP3 inflammasome. Phytomedicine. 2018;41:45\u201353. doi: 10.1016/j.phymed.2018.01.026.", "ArticleIdList": ["10.1016/j.phymed.2018.01.026", "29519318"]}, {"Citation": "Li X., Mei W., Huang Z., Zhang L., Xu B., Shi X., Xiao Y., Ma Z., Liao T., Zhang H. Casticin suppresses monoiodoacetic acid-induced knee osteoarthritis through inhibiting HIF-1\u03b1/NLRP3 inflammasome signaling. Int. Immunopharmacol. 2020;86:106745. doi: 10.1016/j.intimp.2020.106745.", "ArticleIdList": ["10.1016/j.intimp.2020.106745", "32622201"]}, {"Citation": "Cui D., Liu S., Tang M., Lu Y., Zhao M., Mao R., Wang C., Yuan Y., Li L., Chen Y. Phloretin ameliorates hyperuricemia-induced chronic renal dysfunction through inhibiting NLRP3 inflammasome and uric acid reabsorption. Phytomedicine. 2020;66:153111. doi: 10.1016/j.phymed.2019.153111.", "ArticleIdList": ["10.1016/j.phymed.2019.153111", "31790902"]}, {"Citation": "Wang Y.-J., Chen Y.-Y., Hsiao C.-M., Pan M.-H., Wang B.-J., Chen Y.-C., Ho C.-T., Huang K.-C., Chen R.-J. Induction of autophagy by pterostilbene contributes to the prevention of renal fibrosis via attenuating NLRP3 inflammasome activation and epithelial-mesenchymal transition. Front. Cell Dev. Biol. 2020;8:436. doi: 10.3389/fcell.2020.00436.", "ArticleIdList": ["10.3389/fcell.2020.00436", "PMC7283393", "32582712"]}, {"Citation": "Xin R., Sun X., Wang Z., Yuan W., Jiang W., Wang L., Xiang Y., Zhang H., Li X., Hou Y. Apocynin inhibited NLRP3/XIAP signalling to alleviate renal fibrotic injury in rat diabetic nephropathy. Biomed. Pharmacother. 2018;106:1325\u20131331. doi: 10.1016/j.biopha.2018.07.036.", "ArticleIdList": ["10.1016/j.biopha.2018.07.036", "30119203"]}, {"Citation": "Liang Q., Cai W., Zhao Y., Xu H., Tang H., Chen D., Qian F., Sun L. Lycorine ameliorates bleomycin-induced pulmonary fibrosis via inhibiting NLRP3 inflammasome activation and pyroptosis. Pharmacol. Res. 2020;158:104884. doi: 10.1016/j.phrs.2020.104884.", "ArticleIdList": ["10.1016/j.phrs.2020.104884", "32428667"]}, {"Citation": "Mahzari A., Li S., Zhou X., Li D., Fouda S., Alhomrani M., Alzahrani W., Robinson S.R., Ye J.-M. Matrine protects against MCD-induced development of NASH via upregulating HSP72 and downregulating mTOR in a manner distinctive from metformin. Front. Pharmacol. 2019;10:405. doi: 10.3389/fphar.2019.00405.", "ArticleIdList": ["10.3389/fphar.2019.00405", "PMC6491841", "31068812"]}, {"Citation": "Wu X., Zhang F., Xiong X., Lu C., Lian N., Lu Y., Zheng S. Tetramethylpyrazine reduces inflammation in liver fibrosis and inhibits inflammatory cytokine expression in hepatic stellate cells by modulating NLRP 3 inflammasome pathway. IUBMB Life. 2015;67:312\u2013321. doi: 10.1002/iub.1348.", "ArticleIdList": ["10.1002/iub.1348", "25847612"]}, {"Citation": "Liu G., Shi Y., Peng X., Liu H., Peng Y., He L. Astaxanthin attenuates adriamycin-induced focal segmental glomerulosclerosis. Pharmacology. 2015;95:193\u2013200. doi: 10.1159/000381314.", "ArticleIdList": ["10.1159/000381314", "25924598"]}, {"Citation": "Wang L., Ma J., Guo C., Chen C., Yin Z., Zhang X., Chen X. Danggui buxue tang attenuates tubulointerstitial fibrosis via suppressing NLRP3 inflammasome in a rat model of unilateral ureteral obstruction. BioMed Res. Int. 2016;2016 doi: 10.1155/2016/9368483.", "ArticleIdList": ["10.1155/2016/9368483", "PMC5107862", "27872860"]}, {"Citation": "Park J.E., Lee H., Rho H., Hong S.M., Kim S.Y., Lim Y. Effect of Quamoclit angulata extract supplementation on oxidative stress and inflammation on hyperglycemia-induced renal damage in type 2 diabetic mice. Antioxidants. 2020;9:459. doi: 10.3390/antiox9060459.", "ArticleIdList": ["10.3390/antiox9060459", "PMC7346142", "32471242"]}, {"Citation": "Yu C., He Q., Zheng J., Li L.Y., Hou Y.H., Song F.Z. Sulforaphane improves outcomes and slows cerebral ischemic/reperfusion injury via inhibition of NLRP3 inflammasome activation in rats. Int. Immunopharmacol. 2017;45:74\u201378. doi: 10.1016/j.intimp.2017.01.034.", "ArticleIdList": ["10.1016/j.intimp.2017.01.034", "28189971"]}, {"Citation": "Kim J., Ahn H., Han B.-C., Shin H., Kim J.-C., Jung E.-M., Kim J., Yang H., Lee J., Kang S.G. Obovatol inhibits NLRP3, AIM2, and non-canonical inflammasome activation. Phytomedicine. 2019;63:153019. doi: 10.1016/j.phymed.2019.153019.", "ArticleIdList": ["10.1016/j.phymed.2019.153019", "31302317"]}, {"Citation": "Zhou H., Feng L., Xu F., Sun Y., Ma Y., Zhang X., Liu H., Xu G., Wu X., Shen Y. Berberine inhibits palmitate-induced NLRP3 inflammasome activation by triggering autophagy in macrophages: A new mechanism linking berberine to insulin resistance improvement. Biomed. Pharmacother. 2017;89:864\u2013874. doi: 10.1016/j.biopha.2017.03.003.", "ArticleIdList": ["10.1016/j.biopha.2017.03.003", "28282788"]}, {"Citation": "Bagherniya M., Khedmatgozar H., Fakheran O., Xu S., Johnston T.P., Sahebkar A. Medicinal plants and bioactive natural products as inhibitors of NLRP3 inflammasome. Phytother. Res. 2021 doi: 10.1002/ptr.7118.", "ArticleIdList": ["10.1002/ptr.7118", "33856730"]}, {"Citation": "Liu B., Yu J. Anti-NLRP3 Inflammasome Natural Compounds: An Update. Biomedicines. 2021;9:136. doi: 10.3390/biomedicines9020136.", "ArticleIdList": ["10.3390/biomedicines9020136", "PMC7912743", "33535473"]}, {"Citation": "T\u0151zs\u00e9r J., Benk\u0151 S. Natural compounds as regulators of NLRP3 inflammasome-mediated IL-1\u03b2 production. Mediat. Inflamm. 2016;2016 doi: 10.1155/2016/5460302.", "ArticleIdList": ["10.1155/2016/5460302", "PMC5031844", "27672241"]}, {"Citation": "Ding N., Wei B., Fu X., Wang C., Wu Y. Natural Products that Target the NLRP3 Inflammasome to Treat Fibrosis. Front. Pharmacol. 2020;11:2039. doi: 10.3389/fphar.2020.591393.", "ArticleIdList": ["10.3389/fphar.2020.591393", "PMC7773645", "33390969"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "6", "Day": "30"}, {"Year": "2021", "Month": "8", "Day": "1"}, {"Year": "2021", "Month": "8", "Day": "19"}, {"Year": "2021", "Month": "9", "Day": "10", "Hour": "1", "Minute": "8"}, {"Year": "2021", "Month": "9", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "10", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "8", "Day": "31"}], "PublicationStatus": "epublish", "ArticleIdList": ["34502407", "PMC8431520", "10.3390/ijms22179497", "ijms22179497"]}}], "PubmedBookArticle": []}